Nanotherapeutics

About:

Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities,

Website: http://www.nanotherapeutics.com

Twitter/X: Nanotherapeutix

Top Investors: Trinity Capital, Hercules Capital, White Oak Global Advisors

Description:

Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities, and a proprietary pipeline. The Company's technologies can be used with all drug types ranging from small molecules to proteins and peptides. These technologies can be employed with new chemical entities or with generic drugs and can be used with the spectrum of existing drug types ranging from small synthetic molecules to large recombinant macromolecules.

Total Funding Amount:

$66.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Alachua, Florida, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)nanotherapeutics.com

Founders:

James D Talton

Number of Employees:

51-100

Last Funding Date:

2015-03-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai